r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

DE

Dov Elefant

Insider · Chief Financial Officer · FEMY

Dov Elefant files insider transactions with the SEC as a chief financial officer of Femasys (FEMY). We hold 1 disclosed purchase or sale filed since 9 January 2006, 1 of them in the last 90 days.

  • Files forFEMY
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure11 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 28 February 2022 — 7 August 2026Chief Financial Officer · Femasys (FEMY)22 Form 4 lines · source: SEC Form 4
  • Filed 10 September 2019 — 25 January 2022Chief Financial Officer · Cellectar Biosciences (CLRB)8 Form 4 lines · source: SEC Form 4
  • Filed 21 September 2015 — 21 September 2015Chief Financial Officer · Akari Therapeutics (AKTX)1 Form 4 line · source: SEC Form 4
  • Filed 19 March 2007 — 19 March 2007Corporate Controller · Lev Pharmaceuticals (LEVP.OB)2 Form 4 lines · source: SEC Form 4
  • Filed 5 January 2006 — 5 January 2006Controller - VP - Fin & Admin · Epicept (EPCT)1 Form 4 line · source: SEC Form 4

Everything they disclosed

34 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.